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The present invention generally relates to a microcolumn 
capable of Separating an analyte from a Sample in the 
millisecond time domain. The microcolumn is capable of 
Such rapid Separation by employing Small column Volumes 
that can tolerate medium to high flow rates. The invention 
also relates to a method of loading a microcolumn capable 
of Separating an analyte from a Sample in the millisecond 
time domain using plural injections of the packing material. 
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LOADING MICROCOLUMS FOR THE 
SEPARATION OF ANALYTES FROMA 
SAMPLE IN THE MILLISECOND TIME 
SCALE 
FIELD OF THE INVENTION 
The current invention is generally directed toward a 
microcolumn and a method of loading a microcolumn. The 
microcolumn produced by the method of the invention is 
capable of Separating an analyte from a Sample in the 
millisecond time Scale by using Small column volumes that 
can tolerate medium to high flow rates. 
BACKGROUND OF THE INVENTION 
One area of continuing interest in the field of analytical 
chemistry is the development of Separation techniques that 
achieve extraction of an analyte from a Sample in the 
millisecond time domain. The ability to rapidly and accu 
rately Separate analytes from a Sample has a number of 
important applications in the health, pharmaceutical, 
clinical, research and environmental fields. One Such 
application, for example, is the ability to rapidly extract the 
biologically active form of a drug, hormone, or toxin from 
a biological Sample. This is of particular interest in clinical 
chemistry and pharmaceutical Science as a means for con 
trolling and Studying the effect of drugs and/or hormones 
within the body. 
Techniques such as microbore HPLC and capillary HPLC 
have attempted to decrease Separation times and increase 
Separation efficiency by decreasing column diameter with a 
corresponding increase in column length. The Small column 
diameter acts to decrease column volume, while the 
increased column length Serves to provide more contacts 
between the analyte and the Separation medium. Although 
these techniques have increased separation efficiency by 
obtaining narrower elution peaks, they have not resulted in 
Separations in the millisecond time domain. 
In another approach, Some techniques have attempted to 
decrease extraction time by reducing column lengths. Many 
HPLC-based immunoaffinity columns are now in the size 
range of a few millimeters to a few centimeters. However, 
columns with these dimensions, while Separating an analyte 
from a Sample in a few Seconds, cannot achieve Separation 
in the millisecond time domain. Additionally, membrane 
Supports based on polymeric materials that are Several 
millimeters to Several centimeters in diameter and Several 
millimeters in length have been developed. However, like 
the immunoaffinity columns previously discussed, the mem 
brane Supports are not capable of Separating an analyte from 
a Sample in the millisecond time domain. 
Accordingly, a need exists for a column with dimensions 
that are capable of achieving a high rate of Selective Sepa 
ration in the millisecond time domain. 
SUMMARY OF THE INVENTION 
Among the Several aspects of the invention therefore, is 
provided a method of loading a microcolumn comprising an 
active layer and an inert layer, the active layer being capable 
of Separating an analyte from a Sample, the method com 
prising introducing the active layer into the microcolumn 
Such that the active layer is capable of Separating the analyte 
from the Sample within the millisecond time domain, and 
introducing the inert layer. 
Another aspect of the invention is provided a microcol 
umn for Separating an analyte from a Sample, the microcol 
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umn comprising an active layer capable of Separating the 
analyte from the Sample in the millisecond time domain, and 
an inert layer. 
In yet a further aspect is provided a method for Separating 
an analyte from a Sample in the millisecond time domain, the 
method comprising applying the Sample to the microcolumn 
described herein. 
BRIEF DESCRIPTION OF THE DRAWINGS 
These and other features, aspects, and advantages of the 
present invention will become better understood with regard 
to the following description, appended claims and accom 
panying figures where: 
FIG. 1 depicts change in column void time with column 
length and solvent flow rate for 2 mm ID HPLC columns 
packed with porous Silica. These results assume an overall 
porosity of 0.80 within the column (i.e., 80% of the column 
Volume is occupied by the mobile phase). Using a column 
with an inner diameter of 1 mm or 4 mm gives Similar results 
but with the vertical position of the lines in this graph being 
lowered or raised by 4-fold, respectively. 
FIG. 2 depicts a typical microcolumn. This column was 
packed with Nucleosil Si-300 silica and later removed from 
its housing for the acquisition of this image. Immobilized 
hemoglobin Silica, shown as the dark center band, was used 
to visualize the Stationary phase layer after the column was 
unpacked. The total length of the column shown was 1.0 cm 
and the effective length of the stationary phase layer was 620 
tim. The column diameter was 2.1 mm. 
FIG. 3 depicts the reproducibility of stationary phase 
content in a microcolumn as a function of the number of 
injections which were used to apply to fixed amount of an 
immobilized hemoglobin Support to a 2.1 mm IDX620 um 
microcolumn. These results represent the average result of 
triplicate analyses. 
FIG. 4 depicts pressure versus flow rate for columns 
packed with Nucleosil Si-10000 or Nucleosil Si-300 Ol 
Supports. These measurements were performed at room 
temperature using pH 7.0, 0.1M potassium phosphate buffer 
as the mobile phase. The error bars shown about each point 
represent a range of t1 SD for triplicate measurements. 
FIG. 5 depicts the general Scheme used to represent 
analyte extraction by microcolumns. The forward and 
reverse mass transfer rate constants k and k repre 
Sent movement of the analyte (A) from the flowing 
mobile phase to Stagnant mobile phase within the 
Support. The Second-order rate constant k describes 
the actual adsorption of the analyte to the Stationary 
phase. A reverse first-order rate constant for analyte 
desorption could also be included in this model (k); 
however, this was not necessary in this current Study 
Since analyte binding to the column was essentially 
irreversible on the time Scale of the extraction Studies. 
FIG. 6 depicts extraction of fluorescein using an anti 
fluorescein immunoaffinity Support. Microcolumns 
varying in lengths from 124 um to 620 um were used 
for this Study along with various flow rates to adjust the 
column residence times. 
FIG. 7 depicts extraction of hemoglobin using a reversed 
phase chromatographic Support. Microcolumns varying in 
lengths from 62 um to 620 um were used for this Study along 
with various flow rates to adjust the column residence times. 
FIG. 8 depicts a competitive binding immunoassay for 
albumin performed on a column that contained anti-albumin 
antibodies as the Stationary phase. The column was prepared 
and Sample injections were performed as described in the 
US 6,500,671 B2 
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text. Sample injection took place at 0 min in each plot. The 
concentration of FITC-BSA in each sample was 1.6 uM. The 
concentrations of non-labeled BSA were (from left-to-right) 
0, 17.9 and 88.8 uM, respectively. 
FIG. 9 depicts a drawing of a typical microcolumn 
according to the present invention. 
ABBREVIATIONS AND DEFINITION 
To facilitate understanding of the invention, a number of 
terms and abbreviations as used herein are defined below: 
“Analyte” or “Target Analyte” are used interchangeably 
herein, and Shall mean the component of the Sample to be 
Separated by the active layer of the microcolumn. 
“Binding Agent', as utilized herein, shall mean the agent 
in the active layer capable of Separating the target analyte 
from the Sample. 
"Millisecond Time Domain or Millisecond Time Scale” 
are used interchangeably herein, and shall mean any amount 
of time less than one Second. 
"Sandwich microcolumn', as utilized herein, Shall mean 
an embodiment of the invention wherein the microcolumn 
comprises a top inert layer, a bottom inert layer and an active 
layer between the two inert layers. 
“Sample” or “Liquid” are used interchangeably herein 
and shall mean the mixture applied to the microcolumn 
containing the analyte. In addition to the analyte, the Sample 
(liquid) generally also comprises a loading buffer. Any 
loading buffer may be employed to the extent that the buffer 
does not interfere with the Separation process. 
“Uniform Manner”, as utilized herein, shall mean loading 
the layers of the microcolumn in a manner Such that these 
layerS have a Substantially equal distribution of Support in 
both a horizontal and vertical direction. 
BSA=Bovine Serum Albumin 
FPLC=Fast-Protein Liquid Chromatography 
HPLC=High-Performance Liquid Chromatography 
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
Applicants have discovered a new class of microcolumns 
that allows Separation of an analyte from a Sample in the 
millisecond time Scale. The microcolumns achieve Such 
rapid Separation by employing a thin active layer comprising 
Support particles that are capable of tolerating medium to 
high flow rates and pressures during Sample injection, in 
combination with a Small column volume. Applicants have 
also discovered a method of loading a microcolumn in layers 
to obtain a uniform, thin active layer by utilizing a plurality 
of injections to load the column. This provides column 
dimensions that are especially Suitable for very rapid sepa 
ration of an analyte from a Sample. In addition, because of 
the Small column Volumes, the microcolumn also advanta 
geously employs very Small amounts of Support particles. 
This is advantageous because it generally decreases the cost 
of column construction. 
AS utilized herein, the terms “microcolumn” or “column” 
are used interchangeably and FIG. 9 depicts a typical 
microcolumn of the invention. As shown in FIG. 9, the 
microcolumn 1 generally has a tubular configuration with a 
first end 2, a Second end 3, a passageway 4 there between, 
and a retaining means at the first 5 and Second ends 6 of the 
microcolumn 1. However, the microcolumn 1 may comprise 
any number of different shapes, all of which are embodi 
ments of the present invention. The retaining means 5, 6 
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typically comprises a mesh or Small-pore material that acts 
to hold the Support particles within the column while allow 
ing fluid flow there through. The microcolumn 1 may also 
contain end fittings at the first 7 and second 8 ends of the 
microcolumn 1 used to connect the column to the chromato 
graphic System. The microcolumn 1 comprises a thin active 
layer 9 to facilitate Separation of the analyte from the Sample 
in the millisecond time Scale and typically a Single inert 
layer in one embodiment, to Several inert layers in additional 
embodiments. FIG. 9 illustrates an embodiment with a top 
inert layer 10 and a bottom inert layer 11. 
The microcolumn of the present invention is particularly 
Suitable for Separation of an analyte from a Sample in the 
millisecond time Scale because of its relatively thin active 
layer. AS utilized herein, "length' of a layer means the 
thickness or width of the layer. FIG. 1, is a plot (derived by 
calculation) showing how the void time for an HPLC 
column will change as the length of the column and Solvent 
flow rate are varied. As illustrated by FIG. 1, only column 
lengths in the Size range of about 100 microns to about 1 
millimeter or less allow Separation in the millisecond time 
domain when employing standard HPLC flow rates of about 
0.1 to about 1.0 mL/min. Accordingly, in order to facilitate 
millisecond Separation, the microcolumns of the present 
invention comprise an active layer that may be less than 
about 10 microns in thickness. Typically, however, the active 
layer is from about 10 microns to about 1.1 millimeters in 
thickness and preferably, is not less than approximately 60 
microns in thickness. Applicants have found that active 
layers with these dimensions, depending upon the particular 
application, are typically capable of extracting an analyte in 
about 1 to about 500 milliseconds. More preferably, the 
analyte is separated from the Sample in less than about 200 
milliseconds. 
In addition to rapid extraction of the analyte, the micro 
column of the invention is typically capable of Separating 
the target analyte with a high degree of Selectivity. The 
microcolumn, in a particularly preferred embodiment, also 
has a relatively high binding affinity for the target analyte. 
The active layer, therefore, typically comprises Support 
particles derivatized with any binding agent possessing the 
desired Selectivity. For a separation based upon 
immunoaffinity, the binding agents are antibodies raised 
against the target analyte. The antibodies can be either 
monoclonal or polyclonal. However, monoclonal antibodies 
are generally employed in applications where a higher 
degree of Selectivity is desired and polyclonals are more 
typically utilized in applications where a higher degree of 
binding affinity is desired. Examples of other suitable bind 
ing agents for affinity chromatography include nucleic acid 
ligands (e.g. aptamers), Synthetic molecular imprints, anti 
body fragments (e.g. Fab fragments), antibody related mol 
ecules (e.g. chimeras or F chain fragments), and recombi 
nant proteins that act as antibody mimics. Typical Support 
particles for affinity layers include antibodies adsorbed to a 
Protein G Nucleosil Si-1000 (Macherey-Nagel) support or 
any other Support generally known to immobilize antibod 
ies. For a separation that is based on reversed phase 
chromatography, a Support that contains a hydrophobic 
binding agent, such as C18 Nucleosil Si-100 (Marcherey 
Nagel), or any other Support generally known may be 
employed. In addition, for a separation that is based upon 
ion-exchange chromatography, the active Support particles 
may contain anionic or cationic groups on their Surfaces. 
The binding agent, once Selected, may be isolated in accor 
dance with any generally known method. 
The binding agent, if applicable, can be derivatized to the 
Support particles by any method generally known in the art. 
US 6,500,671 B2 
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However, the method preferably immobilizes the binding 
agent to the Support particle in a manner Such that a 
relatively high percent of the binding agent is active (i.e. 
binds the target analyte) after the immobilization process. 
Suitable immobilization methods, for example, include the 
Schiff base method and the carbonyldiimidazole method. 
The Schiff base method is generally employed when immo 
bilizing the binding agent through free amine groups. 
However, when the binding agent comprises antibodies, 
applicants have found that a more preferred approach is 
immobilization through the antibodies carbohydrate region 
because this generally results in an active layer with a higher 
number of active binding Sites compared to when immobi 
lization is performed through free amine groups. Any 
method known in the art for immobilization via carbohy 
drate regions may be employed. 
Additionally, the Overall binding capacity of the micro 
column is also an important feature, particularly when the 
column is employed in methods Such as affinity 
chromatography, because it impacts both the time and effi 
ciency of extraction by the active layer. The binding capacity 
of the column, in part, is determined by the number of active 
binding siteS present in the active layer. Preferably, the 
minimum number of active binding Sites in the column 
comprises a ratio of active binding sites to free analyte not 
less than about 1:1, and more preferably, not less than about 
10:1. However, even more preferably, Support particles in 
the active layer will be derivatized with the maximum 
concentration of active binding agent possible So that the 
column has the largest binding capacity possible. 
The active layer, additionally, may comprise a number of 
different Support particles. The Support particles, as detailed 
above, function primarily as a Surface to immobilize the 
binding agent within the active layer. The diameter of the 
particle, however, is a feature that should be considered 
because it impacts both the length of the active layer and the 
amount of binding agent that may be immobilized in the 
active layer (i.e. binding capacity of the column). Preferably, 
the particle size is Smaller than the length of the desired 
active layer. Applicants have found that a preferred particle 
diameter is less than about 10 times to about 20 times the 
length of the active layer because particles within this size 
range facilitate uniform packing of the layer. Because, 
applicants have found, that a particle diameter about 10 to 
about 20 times less than the active layer thickness allows for 
a better opportunity for small defects in the individual 
Support layers to average out and produces a more uniform 
croSS-Section for this layer. In addition, the Support particles 
should be able to tolerate the flow rates and pressures needed 
in order to obtain the desired Sample contact time with the 
active layer. The properties that affect the pressure and flow 
rate that may be tolerated by the Support particles include the 
diameter of the particle, the particle's shape and the porosity 
of the particles. Suitable Support particles include porous or 
nonporous glass, Silica and other inorganic Supports (e.g., 
alumina or Zirconia), carbohydrate-based Supports (e.g., 
beaded agarose), and polymeric Supports (e.g., poly 
methacryltate or polystyrene based resins); however, one 
generally skilled in the art of chromatography can Select 
other appropriate Support particles. 
The microcolumn will typically comprise a single inert 
layer or Several inert layers, depending upon the application. 
However, common features shared by all inert layers, irre 
spective of their number or position within the 
microcolumn, are that they generally should have no Sub 
Stantial interaction with the desired analyte, and should 
preferably, be mechanically stable under the flow rate and 
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preSSures employed during the Separation process. Prefer 
able materials for construction of the inert layer include 
diol-bonded Silica, diol-bonded glass beads, agarose beads, 
hydroxylated perfusion media, and glycol coated perfusion 
media. The various inert layerS may be constructed from the 
Same Support particles or different Support particles. 
However, it is usually preferred for the Sake of convenience 
in loading the microcolumn, that the inert layers comprise 
the same Support particles. 
The layers in the microcolumn may comprise either an 
active layer alone, or an active layer and a single inert layer 
on top of the active layer (wherein the active layer is in 
communication with the Second end retaining means) Such 
that liquid first passes through the inert layer and then passes 
through the active layer. The utilization of a single inert layer 
in this manner is especially Suitable for applications where 
the liquid (containing the sample) is to be applied in only a 
Single direction to the active layer and the column. The inert 
layer in this application preferably occupies the entire length 
of the microcolumn between the beginning of the first end of 
the microcolumn to the beginning of the active layer So that 
the entire microcolumn is filled with Support particles. 
Applicants have found that having the entire microcolumn 
filled with Support particles increases both the Speed and 
efficiency of Separation. Additionally, the inert layer in this 
application also preferably acts to distribute the injected 
Sample evenly acroSS the diameter of the column before the 
Sample reaches the active layer. This allows for a more 
uniform application of the Sample to the relatively thin 
active layer. 
The layers in the microcolumn may also comprise an 
active layer between a top and a bottom inert layer. AS 
utilized herein, the term “top inert layer” shall mean the 
layer that liquid first passes through prior to reaching the 
active layer and “bottom inert layer” shall mean the layer 
where liquid passes after it exits the active layer. The 
microcolumn preferably comprises both a top and bottom 
inert layer for applications where liquid is to be applied in 
two direction to the active layer and the column. At any 
given time, the flow of liquid through the column is gener 
ally only in a single direction. However, for example, it is 
Sometimes preferable to alternate the flow of liquid through 
the column in order to help wash out any impurities that may 
have built up at the top of the column during the application 
of liquid. The top inert layer in this embodiment serves the 
Same role as discussed above for the application employing 
a single inert layer e.g. more efficient Separation. However, 
applicants have found that it is preferable to include the 
bottom inert layer, even in applications where fluid flow is 
in only in a Single direction, because its inclusion increases 
the useful life of the active layer by preventing loss of active 
Support particles. 
The length of the inert layer is not a critical feature and 
does not affect the time needed to Separate an analyte from 
the sample. In general, as Stated above, the top inert layer (if 
present) is preferably the length that remains between the 
beginning of the column and the beginning of the active 
layer. And, the bottom inert layer, if it is present, is generally 
from about 1 to about 5 times the length of the active layer. 
Typically, the top inert layer is thicker than the bottom inert 
layer. 
The choice of a particular type of housing for the micro 
column is also not a critical facet. The microcolumn 
housing, however, preferably employs components made of 
materials that are Substantially inert to biological fluids and 
in particular, Substantially inert to the analyte So as not to 
interfere with the Separation process. Accordingly, any mate 
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rial that is Substantially inert may be employed to construct 
the microcolumn. Suitable materials include Stainless Steel, 
polypropylene, certain plastics (such as PEEK which is a 
polymer (polyetheretherketone) and is provided in the form 
of HPLC tubing, frits and other HPLC components by 
Upchurch Scientific and fused silica. 
The dimensions of the microcolumn are also not a critical 
feature. Any size of microcolumn may be utilized to the 
extent that the total column length is preferably greater than 
the length of the active layer. The total column length and 
diameter also typically allow the use of sufficiently fast flow 
rates and preSSures to achieve the desired contact time 
between the sample and the active layer. Preferably, the 
microcolumn has an internal diameter of about 50 microns 
to about 2 centimeters and a length of about 0.2 millimeters 
to about 2 centimeters. In a particularly preferred 
embodiment, the microcolumn has an internal diameter of 
about 0.5 to about 2.1 millimeters and a length of about 1 
millimeter to about 2 centimeters. 
Applicants have found that thin active layerS may be 
obtained by loading the Support particles comprising the 
layer into the microcolumn via a plurality of injections, as 
described in more detail below (e.g. see FIG.3). The normal 
method of loading a column, applying the Support particles 
in one application to the column with the amount of Support 
particles being in excess of that which is needed to fill the 
column, is Sufficient for Standard size chromatography col 
umns because due to their size, reliable packing of the 
Support particles may be achieved. Applicants, however, 
have found that loading the Support particles in a Single 
injection, for columns with dimensions described herein, 
generally does not result in an active layer capable of 
reproducibly achieving separation of an analyte from a 
Sample in the millisecond time Scale. 
Accordingly, the layers are preferably loaded into the 
column by a plurality of injections of Slurry comprising the 
Support particles. The Slurry may be injected into the column 
employing any apparatus generally known for injecting a 
Slurry into a column, for example, a closed-loop Sample 
application System with either a manual injection valve or an 
automatic injection System. The Slurry, in addition to Support 
particles, also preferably comprises a packing Solvent or 
buffer. The packing solvent employed to load the slurry into 
the column is not a critical feature; however, the Solvent 
preferably will not harm the binding agent present in the 
active layer. One skilled in the art of chromatography can 
readily Select both an appropriate apparatus to inject the 
Slurry and appropriate packing Solvents. 
Applicants have also found, as illustrated by FIG. 3, 
employing a larger number of injections and leSS Support per 
injection, achieves a more controlled delivery of Support 
particles because Statistical variations that occur during the 
delivery of Small amounts of Support particles to the column 
are averaged out. This is particularly true as layer thickneSS 
decreases. Uniform packing of Support particles in the 
layers, especially the active layer, is preferable because it 
provides more reproducible results for injected Samples by 
allowing parts of the Sample that are injected at different 
locations along the diameter of the column to achieve 
consistent Sample contact times with the active layer. 
Accordingly, the number of injections to introduce a layer 
into the column is generally from about 10 to about 100. 
More preferably, the number of injections to introduce a 
layer is from about 30 to about 40 when the layer length is 
from about 100 to about 500 microns, and is from about 60 
to about 80 injections when the layer length is from about 60 
to about 100 microns in length. 
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The slurry density (milligrams of Support particles per 
milliliter of packing Solvent), or amount of Support particle 
applied to the column per injection, will vary greatly 
depending upon the desired thickness of the layer. Typically, 
however, the slurry density will be from about 0.1 to about 
20 milligrams of Support particles per milliliter of packing 
solvent and more preferably, will be from about 1 to about 
5 milligrams of Support particles per milliliter of packing 
Solvent. In general, the inert layer(s) and active layer are 
loaded at approximately the same slurry density. The Volume 
of slurry injected per application (injection) may also be 
varied as a means to control layer thickness. Typically, the 
Volume of slurry injected per each application is about 50 ul 
to about 300 ul. One of ordinary skill in the art can readily 
determine the appropriate slurry density and Volume per 
injection needed to achieve a layer having a particular 
thickness when employing a specific number of injections. 
For example, equation 2 Set forth in the examples Section 
provides one means to determine the Slurry density to 
achieve a particular layer thickneSS when loading the layer 
into the column by a plurality of injections. 
The desired slurry density, once Selected, is preferably 
maintained throughout column injection in order to facilitate 
uniform layer packing. To maintain consistent Slurry density, 
the Slurry typically undergoes Shaking between injections to 
ensure that the Support particles are uniformly distributed in 
the slurry. It is also preferable to monitor the turbidity of the 
Slurry at a wavelength of approximately 800 nm to ensure 
the amount of Support particles per milliliter remains con 
Stant. Furthermore, typically the slurry density is calculated 
at numerous points during injection by comparison to Slur 
ries of known density employing the same Support particles. 
Applicants have also found, in addition to loading the 
Support particles by a plurality of injections, that varying the 
flow rate and pressure during column loading also serves to 
provide a more stable and well-defined active layer (and 
inert layer). In a particularly preferred application, the 
preSSure and flow rate are increased for a short period of 
time near the beginning and end of the loading of each layer. 
This increased pressure and flow rate facilitates compression 
of the layer and distributes the layer evenly across the 
diameter of the column. In a typical column loading 
procedure, for example, the flow rate of Slurry injection into 
the column is between about 3 mL/min and about 5 mL/min, 
with the higher flow rate occurring generally at the begin 
ning and end of the loading of each layer. Additionally, 
preSSure during column loading is typically maintained 
between about 2000 and about 4000 psi, with a higher 
preSSure preferably occurring at the beginning and end of the 
loading of each layer. The particular flow rates and pressures 
utilized to load each layer of the column is not a critical 
feature and accordingly, may be varied significantly from the 
general examples provided herein depending upon the par 
ticular application. 
Table 1 Sets forth a general procedure for loading a 1.0 cm 
immunoaffinity microcolum employing a layer design com 
prising an active layer between a top and bottom inert layer. 
The procedure set forth in Table 1 is for illustrative purposes 
only and shall not be construed to limit the scope of the 
present invention as described in greater detail herein. 
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TABLE 1. 
General Procedure for Preparing a Microcolumn 
1. Assemble column fittings on the second end of 
he microcolumn (and retaining means) and attach 
he microcolumn to the packing apparatus; 
2 Make two particle support slurries in the 
packing solvent, one consisting of inert support 
particles, and the other containing the active 
support particles. For an immunoaffinity 
microcolumn, the packing solvent employed may be 
pH 7.0, 0.1OM potassium phosphate buffer and the 
slurry of the inert support particles typically 
may contain a diol-bonded material (e.g. 2 mg/mL 
diol-bonded silica). The second slurry contains 
he immunoaffinity support particles at a 
concentration that is determined by utilizing 
equation 2 or any other generally known method (as 
set-forth in the examples below) and the desired 
hickness of the final active layer 
3 Begin flow of the packing solvent through the 
column. This is generally done at a rate of 
approximately 3 mL/min for immunoaffinity 
microcolumns, but is not critical. Make 
approximately five injections (at 150 ul per 
injection for a 1.0 cm long column) of the inert 
support slurry, followed by an increase in flow 
rate to approximately 5 mL/min for approximately 5 
minutes 
4 Return the flow rate to approximately 3 
mL/min and make the required number of injections 
of the active layer (per equation 2 or any other 
generally known method). After making these 
injections, increase the flow rate to 
approximately 5 mL/min for approximately 5 minutes 
5 Return the flow rate to approximately 3 
mL/min and make enough injections of the inert 
support slurry to fill the remainder of the column 
bed 
6 After the column bed has been filled, 
increase the column backpressure to the desired 
level, typically about 3000 to about 4000 psi. 
Allow the column to equilibrate at this pressure 
for at least 30 minutes. Gradually release the 
pressure. Remove the column from the packing 
apparatus and place a frit (retaining means) and 
end fitting onto the open end of the column. The 
column is now ready for use 
The microcolumn, in addition to its relatively thin active 
layer, is also generally able to tolerate flow rates and 
preSSures during Sample injection that are capable of achiev 
ing the desired Sample contact time with the active layer. The 
flow rate and pressure Selected depends not only on the 
Support particles employed in its layer construction, but also 
on the column diameter and upper pressure limit that can be 
tolerated by the chromatographic System. In general, any 
flow rate and preSSure necessary to achieve the desired 
residence time and tolerated by the chromatographic System 
employed is within the Scope of the present invention. 
Typically, however, the microcolumns of the present inven 
tion may be subjected to flow rates of between about 0.01 to 
about 9.0 mL/min and pressures between about to about 
6000 psi. More preferably, the pressure is between about 100 
to about 1500 psi. 
The microcolumns of the present invention may be 
employed in any Separation System and are particularly 
Suitable for applications in which short residence times or 
rapid extractions are desired. Accordingly, the columns may 
be used in any type of liquid chromatography including 
HPLC, FPLC, and ultra high-pressure chromatography. 
These categories preferably include, but are not limited to 
affinity chromatography, immunoaffinity chromatography, 
reversed-phase chromatography, normal phase 
15 
25 
35 
40 
45 
50 
55 
60 
65 
10 
chromatography, adsorption chromatography, ion exchange 
chromatography, chiral chromatography, capillary 
electrochromatography, and Solid-phase extraction or 
microextraction methods. The columns may also be 
employed in gas chromatography and/or Supercritical fluid 
chromatography. In a preferred embodiment, the columns 
are employed in HPLC systems because these systems 
facilitate flow rates and residence times that are preferable 
when utilizing the microcolumns described herein. 
In addition, the microcolumns of the present invention 
may be utilized to Separate any analyte from a Sample. 
Accordingly, in one embodiment the microcolumns may be 
employed to extract an analyte from a biological Sample, 
Such as the biologically active form of a drug or hormone 
from a blood Sample. Additionally, the analyte may com 
prise a protein, bacteria or fragment thereof, Viral particle, 
toxin or environmental agent. Encompassed in another 
embodiment, the microcolumns are used in clinical Sensors 
for the real-time monitoring of drugs, hormones or other 
biological agents during Surgery or in an emergency room. 
Another embodiment encompasses the use of the microcol 
umns for real-time monitoring and feedback control of 
biochemical reactors, Such as to generate biotechnological 
products. In yet another embodiment, is encompassed the 
use of the microcolumns in high-throughput Screening, 
where a large number of Samples must be processed (e.g. 
Screening the interaction of large protein libraries with 
Specific biological agents for use in proteomics). 
Additionally, the microcolumns may be employed for 
Sample pretreatment or handling as part of miniaturized 
Separation and analysis Systems, Such as those based upon 
capillary electrophoresis or capillary electrochromatogra 
phy. 
The detailed description set-forth above is provided to aid 
those skilled in the art in practicing the present invention. 
Even So, this detailed description should not be construed to 
unduly limit the present invention as modifications and 
variation in the embodiments discussed herein can be made 
by those of ordinary skill in the art without departing from 
the Spirit or Scope of the present inventive discovery. 
All publications, patents, patent applications and other 
references cited in this application are herein incorporated 
by reference in their entirety as if each individual 
publication, patent, patent application or other reference 
were specifically and individually indicated to be incorpo 
rated by reference. 
Without further elaboration, it is believed that one skilled 
in the art can, using the preceding description, utilize the 
present invention to its fullest extent. The following pre 
ferred Specific embodiments are, therefore, to be construed 
as merely illustrative, and not imitative of the remainder of 
the disclosure in any way whatsoever. 
EXAMPLES 
The examples illustrate the ability of the microcolumns of 
the present invention to extract an analyte from a Sample in 
the millisecond time range under both adsorption and 
diffusion-limited conditions. The examples also illustrate 
that the microcolumns are able to achieve Such rapid extrac 
tion when used under typical HPLC flow rates and pressure 
conditions. 
Materials and Methods 
Reagents. The bovine hemoglobin, bovine Serum albumin 
(BSA), fluorescein isothiocyanate (FITC)-labeled BSA, 
mouse anti-BSA antibodies and mouse anti-fluorescein anti 
bodies were from Sigma (St. Louis, Mo.). Sodium fluores 
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cein was obtained from Matheson, Coleman and Bell 
(Cincinnati, Ohio). Reagents for the bicinchoninic acid 
(BCA) protein assay were purchased from Pierce (Rockford, 
Ill.). HPLC-grade Nucleosil Si-1000 (7 um particle 
diameter, 1000 A pore size) and Nucleosil Cls Si-100 (5um 
particle diameter, 100 A pore size) were obtained from 
Alltech (Deerfield, Ill.). All other chemicals were reagent 
grade or better and were used without further purification. 
All aqueous Solutions were prepared using deionized water 
from a Nanopure water System (Barnstead, Dubuque, Iowa). 
Apparatus. All columns were packed using a CM3200 
pump from Thermoseparations (Riviera Beach, Fla.) and a 
modified Valco N60 six-port valve (Houston, Tex.). Prior to 
packing, the Support slurries were kept in Suspension by a 
Thermolyne Rotomix 50800 mixer (Dubuque, Iowa). 
Samples for the manual BCA protein assay and Slurry 
turbidity measurements were analyzed using Shimadzu 
UV160U absorbance spectrophotometer (Kyoto, Japan). 
Chromatographic Studies were conducted using an LDC 
CM3200 pump, a model 713 autosampler from 
Thermoseparations, and a Rheodyne 7126 Six-port injection 
valve (Cotati, Calif.). An LDC SM3100X absorbance detec 
tor was used to monitor hemoglobin during its reversed 
phase extraction. The extraction of fluorescein and elution of 
FITC-labeled BSA was examined with a Shimadzu RF-535 
fluorescence detector. 
Microcolumn Preparation. The diol-bonded, aldehyde 
activated, and immobilized protein Supports were prepared 
from Nucleosil Si-1000, as described previously. The micro 
columns were packed using a calibrated injection loop and 
Support slurry of known concentration. The concentration of 
each Slurry was determined in advance by turbidity mea 
Surements at 800 nm verSuS Standard Solutions that con 
tained known concentrations of the Support and packing 
Solvent. 
The permeability Studies were performed in triplicate 
using columns packed with diol-bonded Silica of various 
pore sizes. The back pressure of these columns was mea 
Sured as a function of flow rate between 0.0 and 3.0 mL/min. 
At each new flow rate the system was allowed to stabilize 
before the back preSSure was measured. 
Packing reproducibility was examined by optical microS 
copy and by performing protein assays on microcolumns 
containing immobilized hemoglobin Silica. After packing 
these columns, their contents were removed and examined 
under a microScope or placed into a fixed Volume of pH 7.0, 
0.10 M phosphate buffer. The hemoglobin content of this 
latter Suspension was determined by a BCA protein assay. 
After allowing the color of this assay to develop for 60 min, 
the Support was removed from the reaction Slurry by using 
a 0.45 micron syringe filter and the absorbance of the filtrate 
was measured at 562 nm. 
Chromatographic Studies. All Studies were performed at 
room temperature. The reversed-phase extraction of hemo 
globin was Studied using a 2.1 mm IDX 1.0 cm column which 
contained a 1.1 mm layer of Cs. Nucleosil Si-100; diol 
bonded sillica was used to fill the remainder of the column 
housing. A Series of 10 till injections of a 2 tug/mL hemo 
globin solution were made onto this column in pH 7.0, 0.10 
M phosphate buffer at effective residence times ranging 
from 1-600 ms. The amount of non-retained hemoglobin 
was measured at 428 nm and was compared to the Signal 
obtained when no C Support was present in the chromato 
graphic System. 
The immunoaffinity support for the adsorption-limited 
Studies was prepared by coupling anti-fluorescein antibodies 
to diol-bonded silica through the Schiff base method. Prior 
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to coupling, these antibodies were incubated with fluores 
cein to protect their binding sites from inactivation during 
the immobilization reaction. The immobilized antibodies 
were later washed with pH 2.5, 0.10 M phosphate buffer to 
release the bound fluorescein. This immunoaffinity Support 
was then placed into pH 7.0, 0.10 M phosphate buffer and 
used to pack a 545 um thick layer within a 2.1 mm IDX 1.0 
cm column, with the remainder of the column containing 
diol-bonded silica. A series of 50 ul injections of 5.4 nM 
fluorescein were made onto this column at flow rates of 
0.4-1.1 mL/min using pH 7.0, 0.10 M phosphate buffer as 
the application Solvent. The amount of non-retained fluo 
rescein was monitored by using on-line fluorescence detec 
tion with excitation and emission wavelengths of 488 and 
520 nm, respectively. Between each injection, the column 
was washed with pH 2.5, 0.10 Mphosphate buffer, followed 
by re-equilibration with the pH 7.0 application buffer. The 
relative amount of extracted fluorescein was determined by 
comparing the non-retained peak areas of the anti 
fluorescein column to peak areas measured for the same 
Samples when applied at identical flow rates to a column that 
contained only diol-bonded Silica. 
The immunoaffinity Support for the chromatographic 
competitive binding immunoassay was prepared by adsorb 
ing anti-BSA antibodies to a 2.1 mm IDX 1.0 cm column that 
contained a 1.1 mm thick layer of an immobilized protein G 
Support. Antibodies were placed onto this column by making 
two 50 lull injections of anti-BSA antiserum at a flow rate of 
0.05 mL/min in pH 7.4, 0.10 M phosphate buffer. Samples 
containing FITC-labeled BSA and BSA were injected in the 
same buffer and the amount of non-retained labeled BSA 
was monitored through its fluorescence at excitation and 
emission wavelengths of 488 and 520 nm. The retained BSA 
and labeled BSA were later eluted with pH 2.5, 0.10 M 
phosphate buffer. The column was then re-equilibrated with 
pH 7.4, 0.10 M phosphate buffer before the next sample 
injection. 
Example 1 
Preparation of Microcolumns 
One goal of this work was to decrease the residence times 
that could be obtained with HPLC columns while still 
allowing the use of these columns at Standard flow rates. It 
is difficult to pack an ordinary chromatographic column with 
a length of less then a few millimeters, So a Sandwich-based 
method was used instead. This was accomplished by 
employing a conventional HPLC pump and injection valve 
to apply Slurry of one or more types of Supports to a column. 
Table 1 shows the procedure used to make a typical column 
for this study. For convenience in handling and for protec 
tion of the Stationary phase layer, the column was first filled 
partially with a biologically-inert material, Such as diol 
bonded Silica. After this Support had been placed into the 
column, the flow rate of the packing Solvent was increased 
to ensure that this material was present in an even layer. A 
layer of the desired active Support was next placed into the 
column in a similar manner to give a Sandwich microcol 
umn. The length of this layer was determined by the 
concentration and Volume of the injected Support slurry and 
the number of injections that were made of this slurry. The 
remainder of the column was then filled with diol bonded 
Silica or Some other inert Support to remove any dead Space 
at the head of the column. 
A picture of a typical microcolumn that was prepared for 
this study is shown in FIG. 2. The effective length (L) and 
volume (V) occupied by the stationary phase layer within 
Such a column was adjusted by using the following 
equations, 
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Le=(Nin Vit)/(pro) (2) 
Where C is the concentration of the support in the injected 
slurry, V is the volume of this slurry which was applied 
with each injection, N, is the total number of slurry 
injections that were made of the given Support, p. is the 
packing density of the Support within the column, and r is the 
internal radius of the column. An experimentally-measured 
packing density of 0.64 g/cm was used for the silica 
employed in this work and the calibrated injection volume 
was 152 till. A total of 32 or 64 injections for a particular 
Support was usually employed, as will be discussed later. 
The length of the Support layer was varied by changing the 
density of its injected slurry. In the initial Stages of this work, 
the final lengths of the Support layers in the microcolumns 
were determined by using a colored Support (as shown in 
FIG. 2) and optical microscopy to measure the thickness of 
this layer. In each case, the actual thicknesses of the Sta 
tionary phase layers were found to agree within experimen 
tal error to the lengths that were estimated by using Eqn. 2. 
The total length of all columns used in this work was 1.0 
cm, which included both the Stationary phase-coated Support 
and all inert materials. However, the thickness of the Sta 
tionary phase layer (referred to here as the microcolumn 
“length”) ranged from 1.1 mm to 60 um. Since these 
columns were packed with 5-7 um Silica particles, these 
microcolumns had effective lengths that were equal to only 
9-157 particle diameters. Work with Such small columns 
was possible because the Separations that were to be per 
formed with them were essentially irreversible under the 
time and Solvent conditions that were considered in this 
Study. This gave rise to extractions and assays, which 
generally involved the use of only Single contacts between 
the retained molecules and the Stationary phase. Several 
Specific examples of Such applications are provided below. 
Example 2 
Evaluation of Sandwich Microcolumns 
The reproducibility of microcolumn packing was tested. 
One way this was done was by comparing the total protein 
content of Several columns that had been packed with Small 
layers of an immobilized hemoglobin support. When two 
injections of a 4.8 mg/mL slurry were made of this material, 
this delivered a 620 um thick layer with a precision of 
approximately 20% (+1 RSD). This reproducibility was 
much worse than the precision of only a few percent that was 
observed for the protein assay itself, thus indicating that this 
variability was mainly due to the packing method. Several 
possible Sources of this variability were considered to 
improve the reproducibility of the packing procedure. These 
Sources included 1) potential changes in the slurry density 
between injections and 2) possible variations in the Slurry 
Volume that was applied with each injection onto the col 
U. 
To ensure that the Slurry density remained constant over 
time, this density was routinely monitored by turbidity 
measurements and maintained by Vigorous mixing of the 
Slurry between injections. This resulted in Slurry densities 
that showed less than a few percent variation over even a 
large Series of injections. An approach was also developed 
for minimizing the effects of variations in the injection 
Volume; this was done by using a large number of injections 
of dilute slurry Suspensions to average out Such effects and 
reduce their overall impact. FIG. 3 shows some results that 
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were obtained by this technique for a 620 um Support layer. 
AS can be seen from this plot, an increase in the number of 
Slurry injections (with a corresponding decrease in slurry 
concentration) resulted in a significant improvement in the 
precision of the packing method. In this example a variation 
of less than 5% in support delivery was obtained when using 
32 injections of a 0.3 mg/mL slurry. For longer 
microcolumns, an even better precision was obtained under 
comparable conditions; however, work with Smaller column 
lengths required a greater number of injections to obtain 
Similar results. 
Microcolumns containing a colored Support, like the 
hemoglobin silica shown in FIG. 2, were inspected by 
optical microScopy for their packing uniformity. It was 
found that columns containing Support layers of 60 um in 
length or greater gave level, well-defined boundaries. But 
attempts to pack even Smaller columns gave rise to Some 
edging effects in which the Support layers were no longer 
packed evenly acroSS the diameter of the column. In this 
case, the walls of the column contained a slightly larger layer 
of the colored Support than the Section in the center of the 
column. It is believed that this is due to the presence of Some 
flow heterogeneity within the column during the packing 
procedure. Such an effect was not noticeable or significant 
in the longer microcolumns (effective lengths, 60 um-1.1 
mm) that were used in the remainder of this study. 
Another Series of Studies were performed to determine the 
flow rates and column residence times that could be 
employed with the Sandwich microcolumns. This required 
that some information be obtained on the permeability of 
these columns. This was done by packing Several microcol 
umns with 7 um diameter HPLC-grade silica that had 
nominal pore sizes of 300-4000 A. These supports were 
chosen because they are commonly used for proteins and 
other biological molecules in HPLC. For each type of 
Support, a plot was made of back pressure versus flow rate, 
as shown in FIG. 4. This type of plot was then analyzed by 
using the Darcy equation, 
AP=(uent)/B, (3) 
where U is the linear velocity of the mobile phase, e is 
the columns interstitial porosity, m is the mobile phase 
Viscosity, L is the total column length, AP is the change in 
preSSure acroSS the column, and B is the Specific perme 
ability of the Support within the column. 
According to Eqn. 3, the overall permeability of the 
column (B) can be determined from the slope of plots like 
those in FIG. 4 by converting from flow rate to linear 
Velocity and using the known or measured values of e, m 
and L. The permeabilities that were measured for the sand 
wich microcolumns are given in Table 2 for Several porous 
Silica Supports. Based on these values, the maximum uSable 
flow rates for microcolumns packed with these materials 
were calculated to range from 12 to 17 mL/min at a back 
pressure of 3000 psi; in practice, an upper limit of 9-10 
mL/min was actually observed because of Some non 
linearity that occurred in plots of back pressure verSuS flow 
rate when working at high flow rates (see upper plot in FIG. 
4). However, work at flow rates below this range was more 
than adequate for this Study Since a typical 500 um longx2.1 
mm ID microcolumn allowed Sample residence times of 
40-80 ms to be obtained at 1-2 mL/min. As will be shown 
later, residence times as low as even 1–2 mS could be 
obtained by using shorter columns and/or higher flow rates 
for Sample application. 
Example 3 
Extraction by Sandwich Microcolumns Under 
Adsorption-limited Conditions 
The next series of experiments considered the behavior of 
Sandwich microcolumns in extractions performed in Systems 
US 6,500,671 B2 
15 
with either “diffusion-limited' or “adsorption-limited” 
kinetics for analyte retention. This was based on a model in 
which analyte interaction with the Stationary phase was 
viewed as consisting of two distinct steps (see FIG. 5): 1) 
movement of the analyte to the Surface of the Stationary 
phase by diffusion, and 2) adsorption or interaction of the 
analyte with the stationary phase. The term “diffusion 
limited kinetics” is used here to refer to a system in which 
the overall rate of analyte binding to the Stationary phase is 
dictated by how fast the analyte can get to the Stationary 
phase from the flow mobile phase. For the model shown in 
FIG. 5, this occurs when the rate constant k is much larger 
than k or k . The opposite situation (adsorption-limited 
kinetics) occurs when k and k are much larger thanka. In 
this situation, the analyte gets to the Stationary phase at a rate 
that is much faster than analyte-stationary phase binding, 
thus making this Second process the rate-limiting Step in 
retention. 
The first case, which was examined, was that of a System 
with adsorption-limited kinetics. This was accomplished by 
injecting a Small analyte (fluorescein) onto a column that 
contained anti-fluorescein antibodies attached to HPLC 
grade Silica. Previous Studies have shown that antibody 
antigen Systems. Such as this tend to display adsorption 
limited kinetics when the antibody is part of an HPLC 
column. Each fluorescein Sample was first injected in trip 
licate at various flow rates onto an inert column containing 
only diol-bonded silica, to which fluorescein does not bind, 
in order to determine the total expected peak area. The same 
Sample was then applied to a Sandwich microcolumn of the 
Same overall size as the inert control column, but which now 
contained a well-defined layer of anti-fluorescein antibodies. 
The degree of extraction was then determined by comparing 
the Size of the non-retained peaks for fluorescein on the 
microcolumn to those measured at the same flow rates on the 
control column. 
The results of this experiment are summarized in FIG. 6. 
It was found that greater than 95% extraction of fluorescein 
could be obtained in as little as 100-120 ms with Sandwich 
microcolumns. Previous studies with antibodies attached to 
low-performance agarose Supports have reported greater 
than 95% binding in roughly 100 s or 40% extraction of 
analytes in 2 s, while antibodies attached to HPLC Supports 
have been shown to give quantitative extraction in as little 
as 6 s. However, this present study is the first report in which 
quantitative binding with immunoaffinity Supports has been 
noted in the millisecond time range. Similar Studies were 
conducted with Sandwich microcolumns and antibodies 
directed against other analytes. For instance, the analytes 
L-thyroxine and warfarin have also been found to give 
quantitative extraction in only 60-150 ms by such columns. 
When attempting this type of rapid extraction, it is nec 
essary to consider the amount of Stationary phase that is 
actually present in the column for analyte retention. Increas 
ing the amount of Stationary phase per unit volume not only 
helps avoid column overloading, but in an adsorption 
limited System this also helps to speed the net rate of 
retention by increasing the probability that an analyte will 
encounter an unoccupied binding site as it approaches the 
Stationary phase. Typically, immunoaffinity extractions use a 
large excess of antibodies to help avoid these problems. But 
this can be more difficult to attain in microcolumns, where 
the Space available for the Stationary phase is minimal. To 
address this, the anti-fluorescein antibodies used in this 
study were immobilized under conditions which have pre 
viously been shown to maximize the density of antibodies 
on HPLC-grade silica Supports. This provided an amount of 
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antibodies in the anti-fluorescein microcolumns which was 
roughly 2000 to 3000-times greater than the moles of 
fluorescein that were injected. As can be seen from FIG. 6, 
this level was more then sufficient to allow quantitative 
extractions of fluorescein to be achieved in the Sub-Second 
time domain. 
Example 4 
Extraction by Sandwich Microcolumns Under 
Diffusion-limited Conditions 
The Second type of kinetic case considered was the use of 
Sandwich microcolumns to extract analytes under diffusion 
limited conditions. An example of Such a System is the 
retention of a protein like hemoglobin by a reversed phase 
Support. This was Studied by packing a Sandwich microcol 
umn that contained a 1.1 mm layer of Cs. Silica between 
layers of diol-bonded silica. The degree of extraction of 
hemoglobin Samples was estimated by making a continuous 
Series of protein injections, with no elution Step in between, 
until the column was saturated with hemoglobin. All of the 
peak areas were then compared to those for peaks which 
were generated after column Saturation. A similar compari 
Son was made between the peaks measured on the Cs 
microcolumn and those that were obtained for the same 
Samples on an inert control column that contained only 
diol-bonded silica. 
The data that were obtained with this system are illus 
trated in FIG. 7. It was found that up until the point of 
column Saturation (which occurred after about twenty-four 
100 uL injections of 2 mg/mL hemoglobin) greater than 95% 
of the injected hemoglobin was extracted at residence times 
as short as 4 ms. This was followed by a fairly sharp 
decrease in extraction efficiency at shorter times (i.e., 1-2 
ms). This extraction rate was much faster than what was 
observed in FIG. 6 for the fluorescein/anti-fluorescein sys 
tem. One reason for this is that the fluorescein System had 
adsorption-limited kinetics in which retention was limited 
by the rate at which the analyte could reach unoccupied 
antibody Sites with a proper orientation for binding. In 
contrast to this, the binding of hemoglobin to Cs. Silica is a 
much faster, but leSS Specific, diffusion-limited process that 
involves a greater number of potential binding regions and 
in which many more collisions of hemoglobin with the 
Stationary phase result in analyte retention. 
Example 5 
Use of Sandwich Microcolumns in 
Chromatographic Immunoassays 
The last series of studies considered the use of Sandwich 
microcolumns in a chromatographic immunoassay. This 
type of assay uses immobilized antibodies or antigens as part 
of a chromatographic System for the fast and Selective 
determination of analytes. The most common format for 
Such an assay is the competitive binding mode. In this 
format, analyte in the Sample is incubated with a fixed 
amount of a labeled analyte analog and is applied to a 
column that contains a limited amount of antibodies that can 
bind to both of these species. This is most often done by 
Simultaneously injecting the analyte and its labeled analog 
onto the column, but Sequential injection can also be 
employed. The antibody-bound fraction of both compounds 
is then Separated from the fraction that remains free in 
solution. From this, the amount of labeled analyte that was 
in the free or bound fraction can be determined, thus 
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providing an indirect measure of how much analyte was in 
the original Sample. 
Sandwich microcolumns are attractive for use in Such 
assays because they provide a convenient way of placing a 
Small amount of antibodies into a column while still allow 
ing work to be performed at flow rates and column residence 
times that allow a competition to be established between the 
analyte and its labeled analog. In addition, the use of 
microcolumns will minimize the Surface area to which the 
analyte and label are exposed. This should help reduce 
non-specific binding, which is often a limiting factor in 
determining the lower limit of detection that can be obtained 
in immunoassayS. 
A chromatographic competitive binding immunoassay 
with microcolumns was developed by using the competition 
of labeled and non-labeled BSA as a model. Anti-BSA 
antibodies were first adsorbed to a protein G microcolumn to 
form an immunoaffinity Stationary phase. Various mixtures 
of FITC-labeled BSA and non-labeled BSA were then 
injected onto this column, with the non-retained labeled 
BSA being monitored by an on-line fluorescence detector. 
Some typical chromatograms obtained by this method are 
shown in FIG. 8. The sample on the left contained only a 
Solution of the labeled BSA, while the second and third 
Samples to the right contained the same amount of labeled 
BSA plus either a 10-or 50-fold excess of normal BSA. 
An 80% extraction of labeled BSA was achieved in the 
Sample containing only this labeled compound. Injection of 
this label plus a 10-fold excess of non-labeled BSA yielded 
a 15% decrease in the binding of labeled BSA, and injection 
of the labeled BSA plus a 50-fold excess of non-labeled BSA 
gave a 65% decrease in binding (see FIG. 8). It is this inverse 
relationship between binding of the labeled analog and the 
concentration of the unlabeled analyte, which can be used 
for analyte measurements. For each injected Solution, the 
amount of time the Sample was in contact with the immu 
noaffinity Support was approximately 180 ms. However, a 
signal was not observed until about 5-25s after injection 
due to the additional time that was required for the Sample 
to pass out of the injection loop and through the column, 
connecting tubing and detector. These results clearly indi 
cate that a Sandwich microcolumn can be used to perform 
competitive binding immunoassays on very short time 
scales. This approach is not limited to BSA, but could also 
be employed with any other compounds for which antibod 
ies and an appropriately labeled analog are available. 
In light of the detailed description of the invention and the 
examples presented above, it can be appreciated tha the 
Several aspects of the invention are achieved. 
It is to be understood that the present invention has been 
described in detail by way of illustration and example in 
order to acquaint otherS Skilled in the art with the invention, 
its principles, and its practical application. Particular for 
mulations and processes of the present invention are not 
limited to the descriptions of the Specific embodiments 
presented, but rather the descriptions and examples should 
be viewed in terms of the claims that follow and their 
equivalents. While Some of the examples and descriptions 
above include Some conclusions about the way the invention 
may function, the inventor does not intend to be bound by 
those conclusions and functions, but puts them forth only as 
possible explanations. 
It is to be further understood that the specific embodi 
ments of the present invention as Set forth are not intended 
as being exhaustive or limiting of the invention, and that 
many alternatives, modifications, and variations will be 
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apparent to those of ordinary skill in the art in light of the 
foregoing examples and detailed description. Accordingly, 
this invention is intended to embrace all Such alternatives, 
modifications, and variations that fall within the Spirit and 
Scope of the following claims. 
What is claimed is: 
1. A method of loading a microcolumn comprising an 
active layer and an inert layer, the active layer being capable 
of Separating an analyte from a Sample, the method com 
prising: 
(a) introducing the active layer into the microcolumn by 
a plurality of injections Such that the active layer is 
capable of Separating the analyte from the Sample 
within the millisecond time domain; and 
(b) introducing the inert layer. 
2. The method of claim 1 wherein the active layer is 
introduced into the microcolumn as slurry, the Slurry com 
prising particles that form the active layer and a packing 
Solvent. 
3. The method of claim 2 wherein the particles are 
Selected from the group of materials consisting of porous 
glass, nonporous glass, Silica, inorganic Supports, carbohy 
drate based Supports, and polymeric Supports. 
4. The method of claim 2 wherein the flow rate of slurry 
during injection is varied Such that the flow rate is increased 
at the beginning and end of the introduction of each layer 
loaded into the microcolumn. 
5. The method of claim 2 wherein the pressure during 
Slurry injection is varied Such that the pressure is increased 
at the beginning and end of the introduction of each layer 
loaded into the microcolumn. 
6. The method of claim 1 wherein the inert layer is 
introduced into the microcolumn as slurry, the slurry com 
prising particles that form the inert layer and a packing 
Solvent. 
7. The method of claim 6 wherein the particles are 
Selected from the group of materials consisting of diol 
bonded Silica, diol-bonded glass beads, agarose beads, 
hydroxylated perfusion media, and glycol coated perfusion 
media. 
8. The method of claim 6 wherein the particles comprise 
diol-bonded silica. 
9. The method of claim 6 wherein the particles of the inert 
layer, when the column is in use do not Substantially interact 
with the analyte. 
10. The method of claim 1 wherein the number of 
injections to introduce the active layer into the microcolumn 
is from about 30 to about 40 when the layer length is from 
about 100 to about 500 microns. 
11. The method of claim 1 wherein the number of 
injections to introduce the active layer into the microcolumn 
is from about 60 to about 80 when the layer length is from 
about 60 to about 100 microns. 
12. The method of claim 1 wherein the active layer is 
introduced into the microcolumn as a Slurry, the slurry 
comprising particles that form the active layer and a packing 
Solvent. 
13. The method of claim 12 wherein the slurry density is 
from about 0.1 to about 20 milligrams of particles per 
milliliter of packing Solvent. 
14. The method of claim 12 wherein the slurry density is 
from about 1 to about 5 milligrams of particles per milliliter 
of packing Solvent. 
15. The method of claim 14 wherein a consistent slurry 
density is maintained during injection by mixing the slurry 
between injections and measuring the turbidity of the slurry 
at a wavelength of approximately 800 nm. 
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16. The method of claim 1 wherein the number of 
injections to introduce the active layer into the microcolumn 
is from about 10 to about 100. 
17. The method of claim 1 wherein the particles are 
introduced into the column in a uniform manner. 
18. The method of claim 1 wherein the active layer is from 
about 10 microns to about 1.1 millimeters in length. 
20 
19. The method of claim 1 wherein the active layer is not 
less than about 60 microns in length. 
20. The method of claim 1 wherein the inert layer is at 
5 least about 1 to about 5 times the length of the active layer. 
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